AlphaLens
Research
财报Equal-weightTP $18.50005月7日 · Morgan Stanley

Aeva Continues Progress in Autonomous Driving and Smart City Markets, Revenue Beats Estimates

AEVA
中文EN⚠ quality lint: see notes

Aeva's FMCW Progress Breaks Out of Automotive: Revenue Beat, Two OEM Wins, and Two New Markets

Core Conclusion

Aeva's Q1 2026 revenue of $6.26M (11% beat vs. $4.97M consensus) marks the second consecutive quarter of accelerating commercial momentum. While the headline beat is modest, the supporting evidence—Daimler Truck Atlas sensor shipment for 2027 SOP, a first passenger OEM integrating Atlas Ultra, a second approaching pipeline entry, and the announcement of cityOS smart city (Georgia deployment) plus early optical data center trials—suggests the company is diversifying its revenue base faster than the current valuation implies. The market remains focused on automotive lead times and cash burn, but the emerging non-automotive verticals (cityOS, optical) could deliver nearer-term revenue and de-risk the core thesis. At $16.57, the stock sits near our $18.50 target, offering limited upside without execution acceleration; we maintain Equal-weight, but see asymmetric optionality if new markets inflect.

Market May Be Underpricing Two Things

  1. Technology switching cost: Two major OEMs (Daimler Truck + one undisclosed passenger OEM) that previously used ToF LiDAR chose Aeva's FMCW for series production programs. This suggests a performance/form-factor advantage that is not yet fully discounted in peer-relative comparisons.
  2. Non-automotive revenue acceleration: CityOS (smart city platform with LiDAR traffic monitoring) and optical data center applications are early but have shorter sales cycles than automotive. Market estimates likely still rely heavily on automotive ramp from 2027 onward, underestimating the contribution of these verticals in 2026-2028.

Evidence Chain

  • Automotive: Daimler Truck took shipment of Atlas sensors for 2027 SOP. First passenger OEM integrated Atlas Ultra; second OEM completed initial milestones (could enter pipeline this year). NVIDIA Drive partnership generates new automotive leads (Page 1).
  • Revenue: Q1 $6.26M vs. Street $4.97M and MS $5.00M. Non-GAAP EPS -$0.41 beats Street -$0.44 and MS -$0.47 (Page 2).
  • New verticals: "cityOS" deployed in Georgia using LiDAR for traffic and infrastructure. Early forays into data center optical markets (Page 1).
  • Competitive positioning: Two large OEMs with prior ToF experience selected Aeva's FMCW, implying switching inertia and technology lock-in (Page 1).

Key Risks

  • SOP delay risk: Daimler’s 2027 target and passenger OEM 2028 remain 1-2 years away. Similar enthusiasm in 2018/2019 and 2022/2023 faded before. Programs can become vehicle options or get pushed.
  • LiDAR competition: Chinese players may pressure global pricing on unit margins. Geopolitical insulation is temporary.
  • Technology route risk: Camera-only autonomous solutions could reduce LiDAR TAM to niche, shrinking addressable market below current forecasts.
  • Cash consumption: Cash and short-term investments fell to ~$530M by end-2026 (implied by balance sheet projections). Operating cash burn ~$112M in 2026E, requiring additional financing within 12-18 months (Exhibit 3, Exhibit 4).

Valuation & Trading Implications

We base our $18.50 target on a 3-13x P/S multiple (peer range) applied to CY28 revenue of $182M, discounted at 12% to present (midpoint 8x). Current price $16.57 implies ~11x CY28 P/S, above the midpoint but below the bull case of $30 (20x with faster growth). Bear case at $4.50 (2x) reflects revenue disappointment. Upside catalysts: faster OEM ramp, cityOS/optical revenue acceleration, or additional OEM wins. Downside: delays, competition, cash crunch. The risk/reward is balanced, warranting Equal-weight. If the two new verticals generate $10-20M in revenue before 2027, the bull case becomes more likely; we will monitor quarterly disclosures for evidence. No table appended due to character limit; key financials: FY26E revenue $33.3M, FY28E $182M (Exhibit 2 summary).